Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio Identifier:
First received: March 7, 2000
Last updated: February 19, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2002
  Primary Completion Date: September 2002 (Final data collection date for primary outcome measure)